Yayın:
Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGülbaş, Zafer
dc.contributor.authorMyriam Labopin
dc.contributor.authorAndrea Velardi
dc.contributor.authorMaria Teresa Van Lint
dc.contributor.authorDonald Bunjes
dc.contributor.authorBenedetto Bruno
dc.contributor.authorStella Santarone
dc.contributor.authorJohanna Tischer
dc.contributor.authorYener Koç
dc.contributor.authorDepei Wu
dc.contributor.authorZafer Gülbaş
dc.contributor.authorAnnalisa Ruggeri
dc.contributor.authorFlorent Malard
dc.contributor.authorSimona Piemontese
dc.contributor.authorMaria Teresa Lupo Stanghellini
dc.contributor.authorChiara Bonini
dc.contributor.authorClaudio Bordignon
dc.contributor.authorFabio Ciceri
dc.contributor.authorArnon Nagler
dc.contributor.orcid0000-0003-4514-4748
dc.contributor.orcid0000-0003-3226-9891
dc.contributor.orcid0000-0002-1952-5443
dc.contributor.orcid0000-0002-7299-6770
dc.contributor.orcid0000-0002-5037-0515
dc.contributor.orcid0000-0003-1821-1976
dc.contributor.orcid0000-0002-3919-9649
dc.contributor.orcid0009-0003-3176-9963
dc.contributor.orcid0000-0002-4709-0627
dc.contributor.orcid0000-0002-7261-2765
dc.contributor.orcid0000-0002-3474-0002
dc.contributor.orcid0000-0002-5908-0792
dc.contributor.orcid0000-0003-1382-6939
dc.contributor.orcid0000-0002-0772-1674
dc.contributor.orcid0000-0003-0873-0123
dc.contributor.orcid0000-0002-0763-1265
dc.date.accessioned2025-11-13T10:49:41Z
dc.date.issued2016-12-02
dc.identifier.doihttps://doi.org/10.1182/blood.v128.22.672.672
dc.identifier.endpage672
dc.identifier.issn0006-4971
dc.identifier.issue22
dc.identifier.openalexW2558715094
dc.identifier.startpage672
dc.identifier.urihttps://hdl.handle.net/11421/5378
dc.identifier.urihttps://doi.org/10.1182/blood.v128.22.672.672
dc.identifier.volume128
dc.language.isoen
dc.relation.ispartofBlood
dc.rightsrestrictedAccess
dc.subjectTransplantation
dc.subjectGanciclovir
dc.subjectMedicine
dc.subjectHematopoietic stem cell transplantation
dc.subjectOncology
dc.subjectStem cell
dc.subjectImmunology
dc.subjectSuicide gene
dc.subjectInternal medicine
dc.subjectGenetic enhancement
dc.subjectBiology
dc.subjectHuman cytomegalovirus
dc.titleAllogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5058571002

Dosyalar

Koleksiyonlar

Publications